Metraipolis › archive › dc_6db5642fcb19

Real-life experience of tildrakizumab 200 mg in complex psoriatic patients: a case series — Europe PMC PMID:42523870

Source
Europe PMC (en)
Original
https://europepmc.org/article/MED/42523870
DOI
10.3389/fmed.2026.1788690
License (as archived)
solo-consultazione
Archived
2026-10-18T07:23:57.184Z
SHA-256 of the archived text
e965a3858326fcce0b27554b4f1f192612afc0f14b41f3199956191b2c4a5074
Stable URL of this page
https://metraipolis.com/documento/dc_6db5642fcb19

How to cite

Real-life experience of tildrakizumab 200 mg in complex psoriatic patients: a case series — Europe PMC PMID:42523870 — Europe PMC (en), https://europepmc.org/article/MED/42523870 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_6db5642fcb19 (Metraipolis archive dc_6db5642fcb19, sha256 e965a3858326fcce0b27554b4f1f192612afc0f14b41f3199956191b2c4a5074)
BibTeX
@misc{dc6db5642fcb19,
  title = {Real-life experience of tildrakizumab 200 mg in complex psoriatic patients: a case series — Europe PMC PMID:42523870},
  howpublished = {Europe PMC (en)},
  url = {https://europepmc.org/article/MED/42523870},
  note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_6db5642fcb19; sha256 e965a3858326fcce0b27554b4f1f192612afc0f14b41f3199956191b2c4a5074},
  year = {2026}
}

Archived text

The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/42523870. Agents can read the archived copy with the MCP tool read_document.